aro-aat
aro-aat: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Lead developer: ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
Development Pipeline (1)
| Company | Phase |
|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Phase 1 |
Clinical Trials (1)
A Phase 1 Single and Multiple Dose-Escalating Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Effect of ARO-AAT on Serum Alpha-1 Antitrypsin Levels in Normal Adult Volunteers
Frequently asked questions
Who is developing aro-aat?
aro-aat is being developed by ARROWHEAD PHARMACEUTICALS, INC..
How many clinical trials involve aro-aat?
BioSniper tracks 1 clinical trial involving aro-aat.
Analyze ARROWHEAD PHARMACEUTICALS, INC. & aro-aat with AI
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
- 200 free AI credits / month to run live multi-agent analysis
- Watchlist, catalyst alerts & the biotech event calendar
- Full pipeline, financials & FDA data on every company